Immunomedics Inc.

Immunomedics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
186.83 M
Public Float
125.77 M
Immunomedics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2
Market Cap
$2.71 B
Shares Outstanding
191.54 M
Public Float
170.74 M

Profile

Address
300 The American Road
Morris Plains New Jersey 07950
United States
Employees -
Website http://www.immunomedics.com
Updated 07/08/2019
Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments.

Financials

View All
Created with Highcharts 5.0.14Immunomedics Inc.Net Income. Fiscal year is July-June. All values USD Thousands.35 42535 42548 00248 00259 03759 037153 205153 205273 836273 83620142015201620172018050k100k150k200k250k300k
Created with Highcharts 5.0.14Immunomedics Inc.Sales/Revenue. Fiscal year is July-June. All values USD Thousands.9 0419 0415 6535 6533 2333 2333 0913 0912 1562 1562014201520162017201802k4k6k8k10k

William Fricker
Executive Director & Principal Accounting Officer
Behzad Aghazadeh
Chairman